Although PTX3 may therapeutically aid in altering the proinflammatory milieu in obese individuals, and despite elevated expression of PTX3 mRNA observed in adipose tissue, the circulating level of PTX3 is reduced with obesity. This evidence concerns the gene PTX3 and obesity due to melanocortin 4 receptor deficiency.